アミノフィリンとエッセンシャル・トレモール

Recovery of motor disability and spasticity in post-stroke after repetitive transcranial magnetic stimulation (rTMS).

Brain research bulletin·2008

Long-term follow-up study with repetitive transcranial magnetic stimulation (rTMS) in Parkinson's disease.

Brain research bulletin·2004

Therapeutic and "dose-dependent" effect of repetitive microelectroshock induced by transcranial magnetic stimulation in Parkinson's disease.

Journal of neuroscience research·1999

Improvement in Parkinsonian symptoms after repetitive transcranial magnetic stimulation.

Journal of the neurological sciences·1999

Levels and proteolytic processing of chromogranin A and B and secretogranin II in cerebrospinal fluid in neurological diseases.

Journal of neural transmission (Vienna, Austria : 1996)·1998

Changes in the concentration of amino acids in serum and cerebrospinal fluid of patients with Parkinson's disease.

Journal of the neurological sciences·1997

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Efficient management of EV charging stations and DSTATCOM in distribution systems through POA-DTRSRN approach.

Scientific reports·2026

Updated consensus terminology and definitions in chest electrical impedance tomography.

Physiological measurement·2026

Endolysosomal two-pore channels regulate a conserved entry pathway for enteroviruses.

The Journal of general virology·2026

Transvenous Lead Extraction Versus Abandonment of non-Infected, Superfluous Leads-A Meta-Analysis and Systematic Review.

Pacing and clinical electrophysiology : PACE·2026

Coaxial One-Dimensional Nanowires: Artificial Interface Engineering for Next-Generation Energy Storage.

Small (Weinheim an der Bergstrasse, Germany)·2026

Expanding the phenotypic and genotypic spectrum of <i>KCNT1</i>-related epilepsies.

Brain communications·2026

関連する実験動画

アミノフィリンとエッセンシャル・トレモール

関連する概念動画

Recovery of motor disability and spasticity in post-stroke after repetitive transcranial magnetic stimulation (rTMS).

Long-term follow-up study with repetitive transcranial magnetic stimulation (rTMS) in Parkinson's disease.

Therapeutic and "dose-dependent" effect of repetitive microelectroshock induced by transcranial magnetic stimulation in Parkinson's disease.

Improvement in Parkinsonian symptoms after repetitive transcranial magnetic stimulation.

Levels and proteolytic processing of chromogranin A and B and secretogranin II in cerebrospinal fluid in neurological diseases.

Changes in the concentration of amino acids in serum and cerebrospinal fluid of patients with Parkinson's disease.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Efficient management of EV charging stations and DSTATCOM in distribution systems through POA-DTRSRN approach.

Updated consensus terminology and definitions in chest electrical impedance tomography.

Endolysosomal two-pore channels regulate a conserved entry pathway for enteroviruses.

Transvenous Lead Extraction Versus Abandonment of non-Infected, Superfluous Leads-A Meta-Analysis and Systematic Review.

Coaxial One-Dimensional Nanowires: Artificial Interface Engineering for Next-Generation Energy Storage.

Expanding the phenotypic and genotypic spectrum of <i>KCNT1</i>-related epilepsies.

関連する実験動画

アミノフィリンとエッセンシャル・トレモール

関連する概念動画

関連記事